S-1: Anthropic had $112.4B in cash and $19.3B in short-term investments on June 30, surpassing every non-bank US company except Berkshire Hathaway and Alphabet
Leslie Picker /CNBC:NEWForums:r/finance,r/Economics, andr/wallstreetbetsForums:r/finance:Anthropic's cash pile towers over nearly every U.S. companyr/Economics:Anthropic's cash pile towers over nearly...
Anthropic's S-1 implies a $40T+ annual TAM based on knowledge work's economic value in 2025, topping SpaceX's $28.5T estimate, without explicitly naming TAM
The company's estimated market opportunity, tied to the economic value of work produced by knowledge workers, tops SpaceX's enormous figure from earlier this year
S-1: Anthropic spent ~$2.50 on compute and infrastructure for every $1 of revenue in Q1 2025, falling to under 50 cents in Q2 2026, as it seeks profitability
Tuesday 27 October 2026Tim Fernholz /TechCrunch:Who's really in charge at Anthropic after the IPO?Mary Cunningham /CBS News:Anthropic's IPO filing lists 93 pages of risks. What could possibly go wrong...
Anthropic's S-1 shows an 85% gross margin in H1 from running its models, a reality check for skeptics who said pay-as-you-go model sales wouldn't be profitable
When Anthropic on Monday dropped its long-awaited initial public offering prospectus filing, a lot of the details …
An Anthropic hiring manager says he stopped giving coding interviews because Claude is better at them and tells junior engineers that “hunger beats tenure”
This month, I laid the traditional coding interview to rest. As a hiring manager at Anthropic, I stopped asking candidates to do them.
Anthropic expands its US GSA partnership to give federal, state, local, tribal, and territorial governments a 40% discount on Claude, estimated to save $1B
We are expanding our partnership with the General Services Administration (GSA) through a new agreement that gives government partners …
Anthropic details early drug development work with six partners and says it has acquired Mithril, a one-person company working on muscular dystrophy
There are many opportunities to speed up drug development, even beyond the most commonly discussed applications of AI, like proposing initial designs for new molecules.